Tauro.I don’t believe US funds have taken any major interest in Neuren .One of the problems for them is that they like having a placement in the company to get set( say $15 million )but at this stage Neuren certainly does not need the money and don’t want to dilute existing shareholders .I think you will find that the top 20 shareholders have not changed with the exception of Lanstead ,in actual fact the top 20 has picked up the majority of shares sold by Lanstead .
Neurology Today, page-15
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $3.531M | 255.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 502 | $13.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |